HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sapphire: precious stone or ersatz?].

Abstract
The SAPPHIRE trial compared the results of carotid endarteriectomy to those of carotid artery stenting with an emboli-protection device in patients with carotid artery stenosis and coexisting conditions that potentially increased the risk posed by endarteriectomy. The trial concluded that stenting was not inferior to endarteriectomy. This publication was selected by the AHA among the "Top Ten of Heart Disease and Stroke Research" for 2004. Yet, from the start, it raised a considerable controversy which was already exposed in the Editorial which appeared in the same issue of the NEJM. The present paper analyses and summarizes the various potential bias which raised suspicion regarding the SAPPHIRE data. It also underlines the fact that the results obtained in the SAPPHIRE surgical series are considerably inferior to those generally cited in the literature, or those obtained locally.
AuthorsR Limet
JournalRevue medicale de Liege (Rev Med Liege) 2005 Jul-Aug Vol. 60 Issue 7-8 Pg. 683-8 ISSN: 0370-629X [Print] Belgium
Vernacular TitleSapphire: pierre précieuse ou ersatz?
PMID16184746 (Publication Type: English Abstract, Journal Article)
Topics
  • Angioplasty, Balloon
  • Carotid Stenosis (therapy)
  • Endarterectomy, Carotid
  • Humans
  • Randomized Controlled Trials as Topic (methods)
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: